Phase I–II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury

Cell Transplantation

Volumn 25, Issue 11, 2016, Pages 1925-1943

  Zhu, Hui ^a,b   Poon, Waisang ^c   Liu, Yansheng ^a,b   Leung, Gilberto Ka Kit ^d   Wong, Yatwa ^d   Feng, Yaping ^a   Ng, Stephanie C P ^c   Tsang, Kam Sze ^c   Sun, David T F ^c   Yeung, David K ^c   Shen, Caihong ^a,b   Niu, Fang ^a,b   Xu, Zhexi ^a,b   Tan, Pengju ^a,b   Tang, Shaofeng ^a   Gao, Hongkun ^a,b   Cha, Yun ^a   So, Kwok Fai ^e,f,g   Fleischaker, Robert ^h   Sun, Dongming ⁱ   Chen, John ^g   Lai, Jan ^g   Cheng, Wendy ^g   Young, Wise ^g,i   more..

^a KUNMING GENERAL HOSPITAL   (China)

^b Kunming Tongren Hospital   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f JINAN UNIVERSITY   (China)

^g China Spinal Cord Injury Network Ltd   (Hong Kong)

^h Vista Biologicals Corporation   (United States)

ⁱ RUTGERS UNIVERSITY   (United States)

Author keywords

Central pattern generator; Lithium; Mononuclear cells; Spinal cord injury (SCI); Umbilical cord blood

Indexed keywords

HLA ANTIGEN; LITHIUM CARBONATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PLACEBO; METHYLPREDNISOLONE;

ADULT; ARTICLE; BLADDER AND BOWEL MANAGEMENT; CELL THERAPY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DECUBITUS; DIFFUSION TENSOR IMAGING; FEMALE; HONG KONG; HUMAN; HYPERTENSION; LEG SWELLING; LOCOMOTION; MALE; MONONUCLEAR CELL; NERVE FIBER; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PNEUMOCEPHALUS; PRIORITY JOURNAL; SAFETY; SPINAL CORD INDEPENDENCE MEASURE; SPINAL CORD INJURY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TIBIA FRACTURE; UMBILICAL CORD BLOOD; VEIN THROMBOSIS; WALKING; WALKING INDEX FOR SPINAL CORD INJURY; WHITE MATTER; WOUND COMPLICATION; WOUND DEHISCENCE; WOUND HEALING; WOUND PAIN; WOUND SWELLING; ADOLESCENT; CLINICAL TRIAL; CONVALESCENCE; CYTOLOGY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; FETUS BLOOD; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD; TRANSPLANTATION; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FETAL BLOOD; HUMANS; LEUKOCYTES, MONONUCLEAR; LITHIUM CARBONATE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PLACEBO EFFECT; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; WALKING; YOUNG ADULT;

EID: 84994727966     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368916X691411     Document Type: Article

References (131)

1. Saporta S, Kim JJ, Willing AE, Fu ES, Davis CD, Sanberg PR. Human umbilical cord blood stem cells infusion in spinal cord injury: Engraftment and beneficial influence on behavior. J Hematother Stem Cell Res. 2003;12(3):271–8.
2. Li HJ, Liu HY, Zhao ZM, Lu SH, Yang RC, Zhu HF, Cai YL, Zhang QJ, Han ZC. [Transplantation of human umbilical cord stem cells improves neurological function recovery after spinal cord injury in rats]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004;26(1):38–42.
3. Zhao ZM, Li HJ, Liu HY, Lu SH, Yang RC, Zhang QJ, Han ZC. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant. 2004;13(2):113–22.
4. Kuh SU, Cho YE, Yoon DH, Kim KN, Ha Y. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 2005; 147(9):985–92; discussion 992.
5. Roussos I, Rodriguez M, Villan D, Ariza A, Rodriguez L, Garcia J. Development of a rat model of spinal cord injury and cellular transplantation. Transplant Proc. 2005; 37(9):4127–30.
6. Nishio Y, Koda M, Kamada T, Someya Y, Yoshinaga K, Okada S, Harada H, Okawa A, Moriya H, Yamazaki M. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J Neurosurg Spine 2006;5(5):424–33.
7. Dasari VR, Spomar DG, Gondi CS, Sloffer CA, Saving KL, Gujrati M, Rao JS, Dinh DH. Axonal remyelination by cord blood stem cells after spinal cord injury. J Neurotrauma 2007;24(2):391–410.
8. Chen CT, Foo NH, Liu WS, Chen SH. Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms. Pediatr Neonatol. 2008;49(3):77–83.
9. Dasari VR, Spomar DG, Li L, Gujrati M, Rao JS, Dinh DH. Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochem Res. 2008;33(1):134–49.
10. Kao CH, Chen SH, Chio CC, Lin MT. Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock 2008;29(1):49–55.
11. Chua SJ, Bielecki R, Yamanaka N, Fehlings MG, Rogers IM, Casper RF. The effect of umbilical cord blood cells on outcomes after experimental traumatic spinal cord injury. Spine (Phila Pa 1976) 2010;35(16):1520–6.
12. Deng XY, Zhou RP, Lu KW, Jin DD. [Lithium chloride combined with human umbilical cord blood mesenchymal stem cell transplantation for treatment of spinal cord injury in rats]. Nan Fang Yi Ke Da Xue Xue Bao 2010;30(11):2436–9.
13. Erdogan B, Bavbek M, Sahin IF, Caner H, Ozen O, Denkbas EB, Altinors MN. Fetal allogeneic umbilical cord cell transplantation improves motor function in spinal cord-injured rats. Turk Neurosurg. 2010;20(3):286–94.
14. Hu SL, Luo HS, Li JT, Xia YZ, Li L, Zhang LJ, Meng H, Cui GY, Chen Z, Wu N, Lin JK, Zhu G, Feng H. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit Care Med. 2010;38(11):2181–9.
15. Kaner T, Karadag T, Cirak B, Erken HA, Karabulut A, Kiroglu Y, Akkaya S, Acar F, Coskun E, Genc O, Colakoglu N. The effects of human umbilical cord blood transplantation in rats with experimentally induced spinal cord injury. J Neurosurg Spine 2010;13(4):543–51.
16. Rodrigues LP, Iglesias D, Nicola FC, Steffens D, Valentim L, Witczak A, Zanatta G, Achaval M, Pranke P, Netto CA. Transplantation of mononuclear cells from human umbilical cord blood promotes functional recovery after traumatic spinal cord injury in Wistar rats. Braz J Med Biol Res. 2012;45(1):49–57.
17. Erdogan B, Yaycioglu O, Feride Sahin I, Kayaselcuk F, Cemil B, Cemal Gokce E, Bavbek M. The effects of fetal allogeneic umbilical cord tissue transplant following experimental spinal cord injury on urinary bladder morphology. Neurol Neurochir Pol. 2013;47(2):138–44.
18. Schira J, Gasis M, Estrada V, Hendricks M, Schmitz C, Trapp T, Kruse F, Kogler G, Wernet P, Hartung HP, Muller HW. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain 2012;135(Pt 2):431–46.
19. Lim JH, Byeon YE, Ryu HH, Jeong YH, Lee YW, Kim WH, Kang KS, Kweon OK. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Sci. 2007;8(3):275–82.
20. Lee SH, Chung YN, Kim YH, Kim YJ, Park JP, Kwon DK, Kwon OS, Heo JH, Kim YH, Ryu S, Kang HJ, Paek SH, Wang KC, Kim SU, Yoon BW. Effects of human neural stem cell transplantation in canine spinal cord hemisection. Neurol Res. 2009;31(9):996–1002.
21. Lee JH, Chang HS, Kang EH, Chung DJ, Choi CB, Lee JH, Hwang SH, Han H, Kim HY. Percutaneous transplantation of human umbilical cord blood-derived multipotent stem cells in a canine model of spinal cord injury. J Neurosurg Spine 2009;11(6):749–57.
22. Lee JH, Chung WH, Kang EH, Chung DJ, Choi CB, Chang HS, Lee JH, Hwang SH, Han H, Choe BY, Kim HY. Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury. J Neurol Sci. 2011;300(1–2):86–96.
23. Park SS, Byeon YE, Ryu HH, Kang BJ, Kim Y, Kim WH, Kang KS, Han HJ, Kweon OK. Comparison of canine umbilical cord blood-derived mesenchymal stem cell transplantation times: Involvement of astrogliosis, inflammation, intracellular actin cytoskeleton pathways, and neurotrophin-3. Cell Transplant. 2011;20(11–12): 1867–80.
24. Ryu HH, Kang BJ, Park SS, Kim Y, Sung GJ, Woo HM, Kim WH, Kweon OK. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton’s jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci. 2012;74(12):1617–30.
25. Chen SH, Huang KF, Lin MT, Chang FM. Human umbilical cord blood cells or estrogen may be beneficial in treating heatstroke. Taiwan J Obstet Gynecol. 2007;46(1):15–25.
26. Ryabov SI, Zvyagintseva MA, Pavlovich ER, Smirnov VA, Grin AA, Chekhonin VP. Efficiency of transplantation of human placental/umbilical blood cells to rats with severe spinal cord injury. Bull Exp Biol Med. 2014; 157 (1):85–8.
27. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, Oh W, Chang JW, Jeun SS. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther. 2011;2(5):38.
28. Judas GI, Ferreira SG, Simas R, Sannomiya P, Benicio A, da Silva LF, Moreira LF. Intrathecal injection of human umbilical cord blood stem cells attenuates spinal cord ischaemic compromise in rats. Interact Cardiovasc Thorac Surg. 2014;18(6):757–62.
29. Seo MS, Jeong YH, Park JR, Park SB, Rho KH, Kim HS, Yu KR, Lee SH, Jung JW, Lee YS, Kang KS. Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci. 2009;10(3):181–7.
30. Dasari VR, Veeravalli KK, Tsung AJ, Gondi CS, Gujrati M, Dinh DH, Rao JS. Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury. J Neurotrauma 2009;26(11):2057–69.
31. Veeravalli KK, Dasari VR, Tsung AJ, Dinh DH, Gujrati M, Fassett D, Rao JS. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol Dis. 2009;36(1):200–12.
32. Veeravalli KK, Dasari VR, Tsung AJ, Dinh DH, Gujrati M, Fassett D, Rao JS. Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury. Neurochem Res. 2009;34(7):1183–94.
33. Willenbrock S, Knippenberg S, Meier M, Hass R, Wefstaedt P, Nolte I, Murua Escobar H, Petri S. In vivo MRI of intraspinally injected SPIO-labelled human CD34+ cells in a transgenic mouse model of ALS. In Vivo 2012;26(1):31–8.
34. Xiang L, Chen Y. Stem cell transplantation for treating spinal cord injury: A literature comparison between studies of stem cells obtained from various sources. Neural Regen Res. 2012;7(16):1256–63.
35. Ning G, Tang L, Wu Q, Li Y, Li Y, Zhang C, Feng S. Human umbilical cord blood stem cells for spinal cord injury: Early transplantation results in better local angiogenesis. Regen Med. 2013;8(3):271–81.
36. Cao FJ, Feng SQ. Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chin Med J (Engl) 2009;122(2):225–31.
37. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: State of the art. Int J Clin Exp Med. 2010;3(4):248–69.
38. Momin EN, Mohyeldin A, Zaidi HA, Vela G, Quinones-Hinojosa A. Mesenchymal stem cells: New approaches for the treatment of neurological diseases. Curr Stem Cell Res Ther. 2010;5(4):326–44.
39. Park SI, Lim JY, Jeong CH, Kim SM, Jun JA, Jeun SS, Oh WI. Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. J Biomed Biotechnol. 2012;2012:362473.
40. Chen M, Xiang Z, Cai J. The anti-apoptotic and neuroprotective effects of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) on acute optic nerve injury is transient. Brain Res. 2013;1532:63–75.
41. Chung WH, Park SA, Lee JH, Chung DJ, Yang WJ, Kang EH, Choi CB, Chang HS, Kim DH, Hwang SH, Han H, Kim HY. Percutaneous transplantation of human umbilical cord-derived mesenchymal stem cells in a dog suspected to have fibrocartilaginous embolic myelopathy. J Vet Sci. 2013;14(4):495–7.
42. Liu J, Chen J, Liu B, Yang C, Xie D, Zheng X, Xu S, Chen T, Wang L, Zhang Z, Bai X, Jin D. Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats. J Neurol Sci. 2013;325(1–2):127–36.
43. Roh DH, Seo MS, Choi HS, Park SB, Han HJ, Beitz AJ, Kang KS, Lee JH. Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats. Cell Transplant. 2013;22(9):1577–90.
44. Vawda R, Fehlings MG. Mesenchymal cells in the treatment of spinal cord injury: Current & future perspectives. Curr Stem Cell Res Ther. 2013;8(1):25–38.
45. Cui B, Li E, Yang B, Wang B. Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury. Exp Ther Med. 2014;7(5):1233–1236.
46. Chung HJ, Chung WH, Lee JH, Chung DJ, Yang WJ, Lee AJ, Choi CB, Chang HS, Kim DH, Suh HJ, Lee DH, Hwang SH, Do SH, Kim HY. Expression of neurotrophic factors in injured spinal cord after transplantation of human-umbilical cord blood stem cells in rats. J Vet Sci. 2016;17:97–102.
47. Ryu HH, Byeon YE, Park SS, Kang BJ, Seo MS, Park SB, Kim WH, Kang KS, Kweon OK. Immuno-histomorphometric analysis of transplanted umbilical cord blood-derived mesenchymal stem cells and the resulting anti-inflammatory effects on nerve regeneration of injured canine spinal cord. Tissue Eng Regen Med. 2011;8(2):173–182.
48. Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, Schwalenstocker B, Hermann A, Brenner R, Lukomska B, Domanska-Janik K, Ludolph AC, Storch A. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: Limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm (Vienna) 2007;114(11): 1395–406.
49. Cho SR, Yang MS, Yim SH, Park JH, Lee JE, Eom YW, Jang IK, Kim HE, Park JS, Kim HO, Lee BH, Park CI, Kim YJ. Neurally induced umbilical cord blood cells modestly repair injured spinal cords. Neuroreport 2008; 19(13):1259–63.
50. Rizvanov AA, Kiyasov AP, Gaziziov IM, Yilmaz TS, Kaligin MS, Andreeva DI, Shafigullina AK, Guseva DS, Kiselev SL, Matin K, Palotas A, Islamov RR. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis—A novel approach in stem cell therapy. Neurochem Int. 2008;53(6–8): 389–94.
51. Song S, Sanchez-Ramos J. Preparation of neural progenitors from bone marrow and umbilical cord blood. Methods Mol Biol. 2008;438:123–34.
52. Shaimardanova GF, Mukhamedshina Ia O, Arkhipova SS, Salafutdinov, II, Rizvanov AA, Chelyshev Iu A. [Post-traumatic changes of rat spinal cord after transplantation of human umbilical cord blood mononuclear cells transfected with VEGF and FGF2 genes]. Morfologiia 2011;140(6):36–42.
53. Rizvanov AA, Guseva DS, Salafutdinov, II, Kudryashova NV, Bashirov FV, Kiyasov AP, Yalvac ME, Gazizov IM, Kaligin MS, Sahin F, Mukhamedyarov MA, Palotas A, Islamov RR. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice. Exp Biol Med (Maywood) 2011;236(1):91–8.
54. Shaymardanova GF, Mukhamedshina YO, Salafutdinov, II, Rizvanov AA, Chelyshev YA. Usage of plasmid vector carrying vegf and fgf2 genes after spinal cord injury in rats. Bull Exp Biol Med. 2013;154(4):544–7.
55. Mukhamedshina YO, Shaymardanova GF, Garanina EE, Salafutdinov II, Rizvanov AA, Islamov RR, Chelyshev YA. Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat. Spinal Cord 2016;54(5):347–59.
56. Silva NA, Gimble JM, Sousa N, Reis RL, Salgado AJ. Combining adult stem cells and olfactory ensheathing cells: The secretome effect. Stem Cells Dev. 2013;22(8):1232–40.
57. Wang G, Zhang Q, Han Z. Evaluation of neurological function recovery following human umbilical cord mesenchymal stem cells transplantation to injured spinal cord in rats. Chin J Neurosurg (Chin) 2006;22:18–21.
58. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS. Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord. PLoS One 2008;3(10):e3336.
59. Zwart I, Hill AJ, Girdlestone J, Manca MF, Navarrete R, Navarrete C, Jen LS. Analysis of neural potential of human umbilical cord blood-derived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli. J Neurosci Res. 2008;86(9):1902–15.
60. Hu SL, Zhang JQ, Hu X, Hu R, Luo HS, Li F, Xia YZ, Li JT, Lin JK, Zhu G, Feng H. In vitro labeling of human umbilical cord mesenchymal stem cells with super-paramagnetic iron oxide nanoparticles. J Cell Biochem. 2009;108(2):529–35.
61. Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler. 2009;15(5):644–6.
62. Zhang L, Zhang HT, Hong SQ, Ma X, Jiang XD, Xu RX. Cografted Wharton’s jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. Neurochem Res. 2009;34(11):2030–9.
63. Zhu Y, Feng S, Wang X. [Repair of spinal cord injury with rats’ umbilical cord MSCs]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2009;23(12):1491–6.
64. Shang AJ, Hong SQ, Xu Q, Wang HY, Yang Y, Wang ZF, Xu BN, Jiang XD, Xu RX. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res. 2011;1391:102–13.
65. Yan-Wu G, Yi-Quan K, Ming L, Ying-Qian C, Xiao-Dan J, Shi-Zhong Z, Wang-Ming Z, Chuan-Zhi D. Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury. Neurochem Res. 2011;36(5):783–92.
66. Dalous J, Larghero J, Baud O. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: Technical aspects, preclinical studies, and clinical perspectives. Pediatr Res. 2012;71(4 Pt 2):482–90.
67. Hu SL, Lu PG, Zhang LJ, Li F, Chen Z, Wu N, Meng H, Lin JK, Feng H. In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells. J Cell Biochem. 2012;113(3):1005–12.
68. Zhou Z, Zhang H, Jin A, Min S, Yu B, Chen Y. A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury. Brain Res. 2012;1481:79–89.
69. Chen H, Zhang Y, Yang Z, Zhang H. Human umbilical cord Wharton’s jelly-derived oligodendrocyte precursor-like cells for axon and myelin sheath regeneration. Neural Regen Res. 2013;8(10):890–9.
70. Li WW, Wei YH, Li H, Lai DM, Lin TN. Isolation and characterization of a novel strain of mesenchymal stem cells from mouse umbilical cord: Potential application in cell-based therapy. PLoS One 2013;8(8):e74478.
71. Liu R, Zhang Z, Lu Z, Borlongan C, Pan J, Chen J, Qian L, Liu Z, Zhu L, Zhang J, Xu Y. Human umbilical cord stem cells ameliorate experimental autoimmune encephalomy-elitis by regulating immunoinflammation and remyelination. Stem Cells Dev. 2013;22(7):1053–62.
72. Zhu SF, Zhong ZN, Fu XF, Peng DX, Lu GH, Li WH, Xu HY, Hu HB, He JM, Su WY, He YL. Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells. Neurosci Lett. 2013;541:77–82.
73. Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: A review. World J Stem Cells 2014;6(2):120–33.
74. Wakao S, Matsuse D, Dezawa M. Mesenchymal stem cells as a source of Schwann cells: Their anticipated use in peripheral nerve regeneration. Cells Tissues Organs 2014;200(1): 31–41.
75. Wei L, Zhang J, Xiao XB, Mai HX, Zheng K, Sun WL, Wang L, Liang F, Yang ZL, Liu Y, Wang YQ, Li ZF, Wang JN, Zhang WJ, You H. Multiple injections of human umbilical cord-derived mesenchymal stromal cells through the tail vein improve microcirculation and the microenviron-ment in a rat model of radiation myelopathy. J Transl Med. 2014;12:246.
76. Li C, Chen X, Qiao S, Liu X, Liu C, Zhu D, Su J, Wang Z. Effects of Wharton’s jelly cells of the human umbilical cord on acute spinal cord injury in rats, and expression of interleukin-1beta and nerve growth factor in spinal cord tissues. Artif Cells Nanomed Biotechnol. 2015:1–5.
77. Violatto MB, Santangelo C, Capelli C, Frapolli R, Ferrari R, Sitia L, Tortarolo M, Talamini L, Previdi S, Moscatelli D, Salmona M, Introna M, Bendotti C, Bigini P. Longitudinal tracking of triple labeled umbilical cord derived mesenchymal stromal cells in a mouse model of amyotrophic lateral sclerosis. Stem Cell Res. 2015; 15(1):243–53.
78. You H, Wei L, Zhang J, Wang JN. Vascular endothelial growth factor enhanced the angiogenesis response of human umbilical cord-derived mesenchymal stromal cells in a rat model of radiation myelopathy. Neurochem Res. 2015;40(9):1892–903.
79. Zhang J, Li LB, Qiu Z, Ren HB, Wu JY, Wang T, Bao ZH, Yang JF, Zheng K, Li SL, Wei L, You H. Intravenous injections of human mesenchymal stromal cells modulated the redox state in a rat model of radiation myelopathy. Evid Based Complement Alternat Med. 2015;2015:432369.
80. Sarnowska A, Jurga M, Buzanska L, Filipkowski RK, Duniec K, Domanska-Janik K. Bilateral interaction between cord blood-derived human neural stem cells and organotypic rat hippocampal culture. Stem Cells Dev. 2009;18(8):1191–200.
81. Markiewicz I, Sypecka J, Domanska-Janik K, Wyszomirski T, Lukomska B. Cellular environment directs differentiation of human umbilical cord blood-derived neural stem cells in vitro. J Histochem Cytochem. 2011;59(3):289–301.
82. Jablonska A, Kozlowska H, Markiewicz I, Domanska-Janik K, Lukomska B. Transplantation of neural stem cells derived from human cord blood to the brain of adult and neonatal rats. Acta Neurobiol Exp (Wars) 2010;70(4):337–50.
83. Janowski M, Lukomska B, Domanska-Janik K. Migratory capabilities of human umbilical cord blood-derived neural stem cells (HUCB-NSC) in vitro. Acta Neurobiol Exp (Wars) 2011;71(1):24–35.
84. Zhang HT, Chen H, Zhao H, Dai YW, Xu RX. Neural stem cells differentiation ability of human umbilical cord mesenchymal stromal cells is not altered by cryopreserva-tion. Neurosci Lett. 2011;487(1):118–22.
85. Szablowska-Gadomska I, Sypecka J, Zayat V, Podobinska M, Pastwinska A, Pienkowska-Grela B, Buzanska L. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. Acta Neurobiol Exp (Wars) 2012; 72(4):337–50.
86. Young W. Review of lithium effects on brain and blood. Cell Transplant. 2009;18(9):951–75.
87. Zhu Z, Kremer P, Tadmori I, Ren Y, Sun D, He X, Young W. Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta. PLoS One 2011;6(9):e23341.
88. Yick LW, So KF, Cheung PT, Wu WT. Lithium chloride reinforces the regeneration-promoting effect of chon-droitinase ABC on rubrospinal neurons after spinal cord injury. J Neurotrauma 2004;21(7):932–43.
89. Su H, Chu TH, Wu W. Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol. 2007;206(2):296–307.
90. Dill J, Wang H, Zhou F, Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci. 2008;28(36):8914–28.
91. Sun D, Young W. Lithium stimulation of cord blood stem cell proliferation and growth factor production. United States patent US 8852938 B2.
92. Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, Song CH, Han H. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: A case study. Cytotherapy 2005;7(4):368–73.
93. Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: A case report. Int Arch Med. 2010;3:30.
94. Cordes AL, Jahn K, Hass R, Schwabe K, Weissinger EM, Ganser A, Gotz F, Dengler R, Krauss JK, Petri S. Intra-medullary spinal cord implantation of human CD34+ umbilical cord-derived cells in ALS. Amyotroph Lateral Scler. 2011;12(5):325–30.
95. Yao L, He C, Zhao Y, Wang J, Tang M, Li J, Wu Y, Ao L, Hu X. Human umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injury: Electrophysiological changes and long-term efficacy. Neural Regen Res. 2013;8(5):397–403.
96. Liu J, Han D, Wang Z, Xue M, Zhu L, Yan H, Zheng X, Guo Z, Wang H. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy 2013;15(2):185–91.
97. Miao X, Wu X, Shi W. Umbilical cord mesenchymal stem cells in neurological disorders: A clinical study. Indian J Biochem Biophys. 2015;52(2):140–6.
98. Zhang R, Chen H, Zheng Z, Liu Q, Xu L. Umbilical cord-derived mesenchymal stem cell therapy for neurological disorders via inhibition of mitogen-activated protein kinase pathway-mediated apoptosis. Mol Med Rep. 2015;11(3):1807–12.
99. Dittuno PL, Ditunno JF Jr. Walking index for spinal cord injury (WISCI II): Scale revision. Spinal Cord 2001;39(12):654–6.
100. Morganti B, Scivoletto G, Ditunno P, Ditunno JF, Molinari M. Walking index for spinal cord injury (WISCI): Criterion validation. Spinal Cord 2005;43(1):27–33.
101. Ditunno JF Jr, Barbeau H, Dobkin BH, Elashoff R, Harkema S, Marino RJ, Hauck WW, Apple D, Basso DM, Behrman A, Deforge D, Fugate L, Saulino M, Scott M, Chung J, Spinal Cord Injury Locomotor Trial G. Validity of the walking scale for spinal cord injury and other domains of function in a multicenter clinical trial. Neurorehabil Neural Repair 2007;21(6):539–50.
102. Ditunno JF, Scivoletto G, Patrick M, Biering-Sorensen F, Abel R, Marino R. Validation of the walking index for spinal cord injury in a US and European clinical population. Spinal Cord 2008;46(3):181–8.
103. Ditunno J, Scivoletto G. Clinical relevance of gait research applied to clinical trials in spinal cord injury. Brain Res Bull. 2009;78(1):35–42.
104. Marino RJ, Scivoletto G, Patrick M, Tamburella F, Read MS, Burns AS, Hauck W, Ditunno J Jr. Walking index for spinal cord injury version 2 (WISCI-II) with repeatability of the 10-m walk time: Inter- and intrarater reliabilities. Am J Phys Med Rehabil. 2010;89(1):7–15.
105. Itzkovich M, Gelernter I, Biering-Sorensen F, Weeks C, Laramee MT, Craven BC, Tonack M, Hitzig SL, Glaser E, Zeilig G, Aito S, Scivoletto G, Mecci M, Chadwick RJ, El Masry WS, Osman A, Glass CA, Silva P, Soni BM, Gardner BP, Savic G, Bergstrom EM, Bluvshtein V, Ronen J, Catz A. The Spinal Cord Independence Measure (SCIM) version III: Reliability and validity in a multicenter international study. Disabil Rehabil. 2007;29(24): 1926–33.
106. Anderson K, Aito S, Atkins M, Biering-Sorensen F, Charlifue S, Curt A, Ditunno J, Glass C, Marino R, Marshall R, Mulcahey MJ, Post M, Savic G, Scivoletto G, Catz A, Functional Recovery Outcome Measures Work G. Functional recovery measures for spinal cord injury: An evidence-based review for clinical practice and research. J Spinal Cord Med. 2008;31(2):133–44.
107. Scivoletto G, Glass C, Anderson KD, Galili T, Benjamin Y, Front L, Aidinoff E, Bluvshtein V, Itzkovich M, Aito S, Baroncini I, Benito-Penalva J, Castellano S, Osman A, Silva P, Catz A. An international age- and gender-controlled model for the Spinal Cord Injury Ability Realization Measurement Index (SCI-ARMI). Neurorehabil Neural Repair 2015;29(1):25–32.
108. Haas BM, Bergstrom E, Jamous A, Bennie A. The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury. Spinal Cord 1996;34(9):560–4.
109. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil. 1999;80(9):1013–6.
110. Smith AW, Jamshidi M, Lo SK. Clinical measurement of muscle tone using a velocity-corrected modified Ashworth scale. Am J Phys Med Rehabil. 2002;81(3):202–6.
111. Mehrholz J, Wagner K, Meissner D, Grundmann K, Zange C, Koch R, Pohl M. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: A comparison study. Clin Rehabil. 2005;19(7):751–9.
112. Ansari NN, Naghdi S, Arab TK, Jalaie S. The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: Limb and muscle group effect. NeuroRehabilitation 2008;23(3):231–7.
113. Ghotbi N, Ansari NN, Naghdi S, Hasson S, Jamshidpour B, Amiri S. Inter-rater reliability of the Modified Modified Ashworth Scale in assessing lower limb muscle spasticity. Brain Inj. 2009;23(10):815–9.
114. Craven BC, Morris AR. Modified Ashworth scale reliability for measurement of lower extremity spasticity among patients with SCI. Spinal Cord 2010;48(3):207–13.
115. Kohan AH, Abootalebi S, Khoshnevisan A, Rahgozar M. Comparison of modified Ashworth scale and Hoffmann reflex in study of spasticity. Acta Medica Iranica 2010; 48(3):154–7.
116. Ghotbi N, Nakhostin Ansari N, Naghdi S, Hasson S. Measurement of lower-limb muscle spasticity: Intrarater reliability of Modified Modified Ashworth Scale. J Rehabil Res Dev. 2011;48(1):83–8.
117. Li F, Wu Y, Li X. Test-retest reliability and inter-rater reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in hemiplegic patients with stroke. Eur J Phys Rehabil Med. 2014;50(1):9–15.
118. Mishra C, Ganesh GS. Inter-rater reliability of modified modified Ashworth scale in the assessment of plantar flexor muscle spasticity in patients with spinal cord injury. Physiother Res Int. 2014;19(4):231–7.
119. Ditunno JF Jr, Young W, Donovan WH, Creasey G. The international standards booklet for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Paraplegia 1994;32(2):70–80.
120. Maynard FM Jr, Bracken MB, Creasey G, Ditunno JF Jr, Donovan WH, Ducker TB, Garber SL, Marino RJ, Stover SL, Tator CH, Waters RL, Wilberger JE, Young W. International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord 1997;35(5):266–74.
121. Scivoletto G, Tamburella F, Laurenza L, Torre M, Molinari M, Ditunno JF. Walking Index for Spinal Cord Injury version II in acute spinal cord injury: Reliability and repro-ducibility. Spinal Cord 2014;52(1):65–9.
122. Ackerman P, Morrison SA, McDowell S, Vazquez L. Using the Spinal Cord Independence Measure III to measure functional recovery in a post-acute spinal cord injury program. Spinal Cord 2010;48(5):380–7.
123. Wen H, Reinhardt JD, Gosney JE, Baumberger M, Zhang X, Li J. Spinal cord injury-related chronic pain in victims of the 2008 Sichuan earthquake: A prospective cohort study. Spinal Cord 2013;51(11):857–62.
124. Howard A, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR. Recommendations for donor HLA assessment and matching for allogeneic stem cell transplantation: Consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant. 2015;221:4–7.
125. Zhu H, Feng YP, Young W, You SW, Shen XF, Liu YS, Ju G. Early neurosurgical intervention of spinal cord contusion: An analysis of 30 cases. Chin Med J (Engl) 2008;121(24):2473–8.
126. Manella KJ, Torres J, Field-Fote EC. Restoration of walking function in an individual with chronic complete (AIS A) spinal cord injury. J Rehabil Med. 2010;42(8): 795–8.
127. Muller R, Dietz V. Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion-and H-reflex activity. Clin Neurophysiol. 2006;117(7): 1499–507.
128. Kirshblum S, Millis S, McKinley W, Tulsky D. Late neurologic recovery after traumatic spinal cord injury. Arch Phys Med Rehabil. 2004;85(11):1811–7.
129. Chen A, Xu XM, Kleitman N, Bunge MB. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord. Exp Neurol. 1996;138(2):261–76.
130. Yang ML, Li JJ, So KF, Chen JY, Cheng WS, Wu J, Wang ZM, Gao F, Young W. Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: A double-blind, randomized, placebo-controlled clinical trial. Spinal Cord 2012;50(2):141–6.
131. Young W. Electrical stimulation and motor recovery. Cell Transplant. 2015;24(3):429–46.